TY - JOUR
T1 - Appearance and disappearance of neutralizing antibodies during interferon-beta therapy
AU - Sorensen, P Soelberg
AU - Koch-Henriksen, Nils
AU - Ross, C
AU - Clemmesen, K M
AU - Bendtzen, K
AU - Danish Multiple Sclerosis Study Group
PY - 2005/7/12
Y1 - 2005/7/12
N2 - Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.
AB - Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.
U2 - 10.1212/01.WNL.0000166049.51502.6A
DO - 10.1212/01.WNL.0000166049.51502.6A
M3 - Journal article
C2 - 15888603
SN - 1526-632X
VL - 65
SP - 33
EP - 39
JO - Neurology
JF - Neurology
IS - 1
ER -